vs
Apellis Pharmaceuticals, Inc.（APLS）与Karat Packaging Inc.（KRT）财务数据对比。点击上方公司名可切换其他公司
Apellis Pharmaceuticals, Inc.的季度营收约是Karat Packaging Inc.的1.7倍（$199.9M vs $115.6M），Karat Packaging Inc.净利率更高（5.9% vs -29.5%，领先35.4%），Karat Packaging Inc.同比增速更快（13.7% vs -5.9%），Karat Packaging Inc.自由现金流更多（$15.1M vs $-14.3M），过去两年Karat Packaging Inc.的营收复合增速更高（10.0% vs 7.7%）
Apellis Pharmaceuticals是一家临床阶段生物制药企业，专注于开发调节补体系统的靶向疗法，适应症覆盖年龄相关性黄斑变性继发地图样萎缩等眼科疾病、罕见血液病及自身免疫性疾病，核心市场为美国及欧盟地区。
Karat Packaging Inc.是专业一次性餐饮包装产品生产商及分销商，产品涵盖纸塑杯、食品容器、餐具、杯盖及定制品牌包装方案，主要服务北美地区的连锁餐厅、咖啡馆、餐饮服务商及零售食品客户。
APLS vs KRT — 直观对比
营收规模更大
APLS
是对方的1.7倍
$115.6M
营收增速更快
KRT
高出19.7%
-5.9%
净利率更高
KRT
高出35.4%
-29.5%
自由现金流更多
KRT
多$29.4M
$-14.3M
两年增速更快
KRT
近两年复合增速
7.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $199.9M | $115.6M |
| 净利润 | $-59.0M | $6.8M |
| 毛利率 | — | 34.0% |
| 营业利润率 | -25.6% | 7.3% |
| 净利率 | -29.5% | 5.9% |
| 营收同比 | -5.9% | 13.7% |
| 净利润同比 | -62.2% | 21.3% |
| 每股收益（稀释后） | $-0.40 | $0.34 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收APLSKRT
| Q4 25 | $199.9M | $115.6M | ||
| Q3 25 | $458.6M | $124.5M | ||
| Q2 25 | $178.5M | $124.0M | ||
| Q1 25 | $166.8M | $103.6M | ||
| Q4 24 | $212.5M | $101.6M | ||
| Q3 24 | $196.8M | $112.8M | ||
| Q2 24 | $199.7M | $112.6M | ||
| Q1 24 | $172.3M | $95.6M |
净利润APLSKRT
| Q4 25 | $-59.0M | $6.8M | ||
| Q3 25 | $215.7M | $7.3M | ||
| Q2 25 | $-42.2M | $10.9M | ||
| Q1 25 | $-92.2M | $6.4M | ||
| Q4 24 | $-36.4M | $5.6M | ||
| Q3 24 | $-57.4M | $9.1M | ||
| Q2 24 | $-37.7M | $9.1M | ||
| Q1 24 | $-66.4M | $6.2M |
毛利率APLSKRT
| Q4 25 | — | 34.0% | ||
| Q3 25 | — | 34.5% | ||
| Q2 25 | — | 39.6% | ||
| Q1 25 | — | 39.3% | ||
| Q4 24 | — | 39.2% | ||
| Q3 24 | — | 38.6% | ||
| Q2 24 | — | 38.5% | ||
| Q1 24 | — | 39.3% |
营业利润率APLSKRT
| Q4 25 | -25.6% | 7.3% | ||
| Q3 25 | 48.7% | 6.9% | ||
| Q2 25 | -18.6% | 13.3% | ||
| Q1 25 | -50.0% | 7.5% | ||
| Q4 24 | -12.3% | 7.2% | ||
| Q3 24 | -24.0% | 10.0% | ||
| Q2 24 | -14.7% | 9.9% | ||
| Q1 24 | -36.0% | 8.4% |
净利率APLSKRT
| Q4 25 | -29.5% | 5.9% | ||
| Q3 25 | 47.0% | 5.9% | ||
| Q2 25 | -23.6% | 8.8% | ||
| Q1 25 | -55.3% | 6.2% | ||
| Q4 24 | -17.1% | 5.5% | ||
| Q3 24 | -29.2% | 8.1% | ||
| Q2 24 | -18.9% | 8.1% | ||
| Q1 24 | -38.5% | 6.4% |
每股收益（稀释后）APLSKRT
| Q4 25 | $-0.40 | $0.34 | ||
| Q3 25 | $1.67 | $0.36 | ||
| Q2 25 | $-0.33 | $0.54 | ||
| Q1 25 | $-0.74 | $0.32 | ||
| Q4 24 | $-0.30 | $0.28 | ||
| Q3 24 | $-0.46 | $0.45 | ||
| Q2 24 | $-0.30 | $0.45 | ||
| Q1 24 | $-0.54 | $0.31 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $466.2M | $37.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $370.1M | $149.4M |
| 总资产 | $1.1B | $287.7M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资APLSKRT
| Q4 25 | $466.2M | $37.9M | ||
| Q3 25 | $479.2M | $44.0M | ||
| Q2 25 | $370.0M | $57.0M | ||
| Q1 25 | $358.4M | $56.3M | ||
| Q4 24 | $411.3M | $59.9M | ||
| Q3 24 | $396.9M | $60.4M | ||
| Q2 24 | $360.1M | $52.1M | ||
| Q1 24 | $325.9M | $46.7M |
总债务APLSKRT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $93.1M | — |
股东权益APLSKRT
| Q4 25 | $370.1M | $149.4M | ||
| Q3 25 | $401.2M | $154.5M | ||
| Q2 25 | $156.3M | $155.8M | ||
| Q1 25 | $164.2M | $153.3M | ||
| Q4 24 | $228.5M | $155.6M | ||
| Q3 24 | $237.1M | $157.3M | ||
| Q2 24 | $264.3M | $157.7M | ||
| Q1 24 | $266.7M | $154.4M |
总资产APLSKRT
| Q4 25 | $1.1B | $287.7M | ||
| Q3 25 | $1.1B | $302.8M | ||
| Q2 25 | $821.4M | $321.0M | ||
| Q1 25 | $807.3M | $312.2M | ||
| Q4 24 | $885.1M | $294.5M | ||
| Q3 24 | $901.9M | $306.8M | ||
| Q2 24 | $904.5M | $310.7M | ||
| Q1 24 | $831.9M | $279.0M |
负债/权益比APLSKRT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.35× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-14.2M | $15.4M |
| 自由现金流经营现金流 - 资本支出 | $-14.3M | $15.1M |
| 自由现金流率自由现金流/营收 | -7.1% | 13.1% |
| 资本支出强度资本支出/营收 | 0.1% | 0.2% |
| 现金转化率经营现金流/净利润 | — | 2.26× |
| 过去12个月自由现金流最近4个季度 | $45.0M | $33.1M |
8季度趋势，按日历期对齐
经营现金流APLSKRT
| Q4 25 | $-14.2M | $15.4M | ||
| Q3 25 | $108.5M | $982.0K | ||
| Q2 25 | $4.4M | $9.8M | ||
| Q1 25 | $-53.4M | $7.7M | ||
| Q4 24 | $19.4M | $8.3M | ||
| Q3 24 | $34.1M | $19.5M | ||
| Q2 24 | $-8.3M | $13.7M | ||
| Q1 24 | $-133.0M | $6.6M |
自由现金流APLSKRT
| Q4 25 | $-14.3M | $15.1M | ||
| Q3 25 | $108.3M | $736.0K | ||
| Q2 25 | $4.4M | $9.6M | ||
| Q1 25 | $-53.4M | $7.6M | ||
| Q4 24 | $19.3M | $8.0M | ||
| Q3 24 | — | $19.2M | ||
| Q2 24 | $-8.4M | $13.4M | ||
| Q1 24 | $-133.3M | $6.4M |
自由现金流率APLSKRT
| Q4 25 | -7.1% | 13.1% | ||
| Q3 25 | 23.6% | 0.6% | ||
| Q2 25 | 2.5% | 7.7% | ||
| Q1 25 | -32.0% | 7.4% | ||
| Q4 24 | 9.1% | 7.9% | ||
| Q3 24 | — | 17.0% | ||
| Q2 24 | -4.2% | 11.9% | ||
| Q1 24 | -77.3% | 6.7% |
资本支出强度APLSKRT
| Q4 25 | 0.1% | 0.2% | ||
| Q3 25 | 0.0% | 0.2% | ||
| Q2 25 | 0.0% | 0.1% | ||
| Q1 25 | 0.0% | 0.1% | ||
| Q4 24 | 0.0% | 0.2% | ||
| Q3 24 | 0.0% | 0.3% | ||
| Q2 24 | 0.0% | 0.2% | ||
| Q1 24 | 0.2% | 0.2% |
现金转化率APLSKRT
| Q4 25 | — | 2.26× | ||
| Q3 25 | 0.50× | 0.13× | ||
| Q2 25 | — | 0.89× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | 1.47× | ||
| Q3 24 | — | 2.14× | ||
| Q2 24 | — | 1.50× | ||
| Q1 24 | — | 1.06× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
APLS
| Syfovre | $155.2M | 78% |
| Empaveli Pegcetacoplan | $35.1M | 18% |
| Licensing And Other Revenue | $9.6M | 5% |
KRT
暂无分部数据
